title: Prospects for new antitubercular drugs.
authors.affiliation: GlaxoSmithKline, Gunnels Wood Road, Stevenage, SG1 2NY, UK. ken.5.duncan@gsk.com
authors.forename: Ken
authors.initials: K
authors.lastname: Duncan
authors.forename: Clifton E
authors.initials: CE
authors.lastname: Barry
mesh_terms: D000818:Animals; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D015363:Quinolones / Q000494:pharmacology / Q000627:therapeutic use; D012294:Rifamycins / Q000494:pharmacology / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy* / Q000453:epidemiology
chemical_list: D000995:Antitubercular Agents; D015363:Quinolones; D012294:Rifamycins